An overview of primary endocardial fibroelastosis and chronic viral cardiomyopathy.
D000413:Alaska; D000818:Animals; D000914:Antibodies, Viral; D002462:Cell Membrane / Q000378:metabolism; D002478:Cells, Cultured; D002642:Chick Embryo; D004195:Disease Models, Animal; D004196:Disease Outbreaks; D004562:Electrocardiography; D004695:Endocardial Fibroelastosis / Q000209:etiology*; D005260:Female; D000882:Haplorhini; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000175:diagnosis; D007111:Immunity, Cellular; D050356:Lipid Metabolism; D008208:Lymphatic System / Q000503:physiopathology; D008251:Macaca; D008954:Models, Biological; D009107:Mumps / Q000453:epidemiology; D009109:Mumps virus; D009205:Myocarditis / Q000150:complications*; D009206:Myocardium / Q000276:immunology; D011247:Pregnancy; D011446:Prospective Studies; D012189:Retrospective Studies; D012882:Skin Tests; D014422:Turkeys; D014779:Virus Replication
D000914:Antibodies, Viral